Experiment 635090
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Piper methysticum (PIPERACEAE) |
| Citation | PEPPING,J:. (1999). KAVA: PIPER METHYSTICUM.. 56(10) |
| Amount utilized | |
| Compound isolated | |
| Disease | ADVERSE EFFECTS OF KAVA ARE MINIMAL AT THERAPEUTIC DOSAGES. SEDAITON AND VIGILANCE-LOWERING EFFECTS ARE NOT NONMALLY EXPERIENCED WITH THREAPEUTIC DOSAGES; HOWEVER, MONRNING FATIGUE MAY OCCUR AT THE BEGINNING OF THERAPY. MILD GASTROINTESTINAL DISTURBANCES, VISUAL-ACCOMMODATION DISORDERS, PUPIL DILATION, AND DISORDERS OF OCULOMOTOR EQUILIBRIUM HAVE BEEN REPORTED, USUALLY AT SUPRATHERAPEUTIC DOSAGES. |
| Dose amount | 750.0 MG |
| Number | 3 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | GIVEN TO BOTH SEXES |